Vascular effects of environmental oestrogens: Implications for reproductive and vascular health

Human Reproduction Update

Volumn 6, Issue 4, 2000, Pages 351-363

  Dubey, Raghvendra K ^a,b,c   Rosselli, Marinella ^b   Imthurn, Bruno ^b   Keller, Paul J ^b   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cells; Environmental oestrogens; Smooth muscle cells; Vascular remodelling

Indexed keywords

ESTROGEN; ESTROGEN DERIVATIVE; PHYTOESTROGEN; XENOBIOTIC AGENT;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; FEMALE; FERTILITY; FERTILIZATION; GENITAL SYSTEM; GENITAL SYSTEM DISEASE; HUMAN; HUMAN CELL; IMPOTENCE; INCIDENCE; MALE; OVARY FOLLICLE DEVELOPMENT; PREECLAMPSIA; PRIORITY JOURNAL; REPRODUCTION; SMOOTH MUSCLE FIBER; VASCULARIZATION; XENOBIOTIC METABOLISM;

EID: 0033842324     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.4.351     Document Type: Article

References (138)

1. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
2. Doppler findings in chronic ectopic pregnancy: Case report
3. Ovarian vein thrombosis mimicking ectopic pregnancy
4. Vascular control mechanisms in penile erection: Phylogeny and the inevitability of multiple and overlapping systems
5. Western diet and western diseases: Some hormonal and biochemical mechanisms and associations
6. Serum vascular endothelial growth factor and doppler blood flow velocities in in vitro fertilization: Relevance to ovarian hyperstimulation syndrome and polycystic ovaries
7. Angiogenic activity of the atherosclerotic carotid artery plaque
8. Soy protein versus soy phyto-oestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys
9. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
10. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression
11. Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model
12. Polychlorinated biphenyl (PCB) exposure produces placental vascular and trophoblastic lesions in mink (Mustela vison): A light and electron microscopic study
13. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia
14. Biocides in human follicular fluid
15. Ultrastructural features of the murine cutaneous microvasculature after exposure to polychlorinated biphenyl compounds (PCBs) and benzo-(a)-pyrene
16. A specific breeding problem of sheep on subterranean clover pastures in western Australia
17. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation
18. The use of transvaginal power doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles
19. Vascular derived growth factors: Cell biology, pathophysiology, and pharmacology
20. Insulin like growth factor-1 and platelet derived growth factor BB induce directed migration of human arterial smooth muscle cells via signalling pathways that are distinct from those of proliferation
21. Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin
22. Mutant oocyte low density lipoprotein receptor gene family member causes atherosclerosis and female infertility
23. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptotic cell death in the embryonic vasculature with embryotoxicity
24. Relative levels of thecal blood flow in atretic and non-atretic ovarian follicles of the conscious sheep
25. Follicular vascularity-the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: A preliminary study
26. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall
27. Cardiovascular effects of menopause and oestrogen replacement. The epidemiological evidence
28. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts
29. Uterine artery atherosclerotic disease: Histologic features and clinical correlation
30. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerosis
31. Damage to the erectile function following radical pelvic surgery: Prevalence of veno-occlusive dysfunction
32. Vascular endothelial growth factor (VEGF) in endometriosis
33. Vasodilator-derived nitric oxide inhibits fetal calf serum-and angiotensin-II-induced growth of renal arteriolar smooth muscle cells
34. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotide and angiotensin 1 receptors
35. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells
36. Differential effects of clinically used oestrogen(s) on mitogen-induced growth of human aortic smooth muscle cells
37. 17β-oestradiol, its metabolites and progesterone inhibit cardiac fibroblast growth
38. Phyto-oestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells
39. Oestrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth
40. Clinically used oestrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity
41. Cervical vascular malformation as a cause of antepartum and intrapartum bleeding in three diethylstilbestrol-exposed progeny
42. Genistein, a dietary derived inhibitor of in vitro angiogenesis
43. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
44. Blood vessel growth in the endometrium
45. Postmenopausal oestrogen and progestin use and the risk of cardiovascular disease
46. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro
47. Oestrogen receptor β - Getting in on the action?
48. Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
49. Endothelial-cell permeability and protein kinase C in pre-eclampsia
50. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype
51. The influence of 2,2',4,4',5,5'-hexachlorobiphenyl on the placental blood flow in guinea pigs at a late stage of gestation
52. Linoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells
53. Randomized trial of oestrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
54. Oestrogen inhibits vascular injury response in oestrogen receptor alpha-deficient mice
55. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrate/nitrite) levels in postmenopausal women substituted with 17β-oestradiol valerate and cyproterone acetate or medroxyprogesterone acetate
56. Cell division and the mitotic spindle
57. Effects of PCB and DDT on mink (Mustela vison) during the reproductive season
58. Environmental pollutants as aetiological agents in female reproductive pathology: Placental glycan expression in normal and polychlorinated biphenyl (PCB)-exposed mink
59. Oestrogen inhibits the vascular injury response in oestrogen receptor beta-deficient female mice
60. The effects of polybrominated biphenyls and perchlorinated terphenyls on in vitro fertilization in the mouse
61. Oestrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor
62. Early diagnosis of tubal pregnancy: Changes in tubal blood flow evaluated by endovaginal color Doppler sonography
63. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report
64. Oestradiol accelerates functional endothelial recovery after arterial injury
65. Association of blood pressure and polychlorinated biphenyl levels
66. Inhibition of neovascularization of the eye by dietary factors exemplified by isoflavonoids
67. Interaction of oestrogenic chemicals and phyto-eostrogens with oestrogen receptor β
68. Transvaginal color flow doppler in the assessment of ovarian and uterine blood flow in infertile women
69. Vascular endothelial growth factor in reproductive biology
70. Discordant uterine artery velocity waveforms as a predictor of subsequent miscarriage in early viable pregnancies
71. Embryotoxicity of polychlorinated biphenyls (PCBs) for preimplantation embryos
72. Increased plasma and aortic triglycerides in rabbits after administering 2,3,7,8-tetrachlorodi-benzo-p-dioxin
73. Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists
74. Microvasculature of growing and atretic follicles in the rabbit ovary: A SEM study of corrosion casts
75. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to oestrogen receptors alpha and beta
76. Regulation of prostacyclin and thromboxane production by human umbilical vessels. The effect of oestradiol and progesterone in a superfusion model
77. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
78. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
79. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
80. The protective effects of estrogen on the cardiovascular system
81. Tyrosine phosphorylation, MAPK and PLD in AII stimulated mitogenesis
82. Clinical Review 92: Phyto-oestrogens
83. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation
84. Associations between ultrasound indices of follicular blood flow, oocyte recovery and perimplantation embryo quality
85. Interaction of hydrophobic organic compounds with mercury adsorbed dioleoylphosphatidylcholine monolayers
86. PCB congeners in the rat brain: Selective accumulation and lack of regionalization
87. Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct
88. Morphometric study of the stromal vascularization in peritoneal endometriosis
89. Angiogenesis in gynecology and obstetrics
90. Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells
91. Hormones and vasoprotection
92. Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis
93. Regulation of cytochrome P4501A1 gene expression in vascular smooth muscle cells through aryl hydrocarbon receptor-mediated signal transduction requires a protein synthesis inhibitor
94. Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency
95. Effect of flaxseed ingestion on the menstrual cycle
96. Levels of some organochlorine residues in blood of patients with arteriosclerotic disease
97. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary
98. Endothelial dysfunction in preeclampsia
99. The pathogenesis of atherosclerosis: A perspective for the 1990s
100. Oestradiol inhibits mitogen induced proliferation and migration of human aortic smooth muscle cells: Implications for cardiovascular disease in women
101. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-oestradiol and norethisterone acetate: A two year follow-up study
102. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction
103. Cellular and biochemical mechanisms by which environmental oestrogens may influence the reproduction function
104. 2+ channels in smooth muscle cells
105. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo(a)pyrene
106. Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero
107. Secretion of vascular endothelial growth factor in ovarian cancer
108. Stimulation of pS2 expression by diet-derived compounds
109. Polychlorinated biphenyls: The occurrence of the main congeners in follicular and sperm fluids
110. Oestrogen and endothelial cell angiogenic activity
111. Placental changes due to administration of diethylstilbestrol
112. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
113. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
114. Oestrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Oestradiol as a survival factor
115. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells
116. Cyclic changes of vasculature and vascular phenotypes in normal ovaries
117. 17β-oestradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells
118. Induction of cytochrome CYP1A1 and formation of toxic metabolites of benzo(a)pyrene by rat aorta: A possible role in atherogenesis
119. Vascular resistance in uterine and ovarian arteries: Its association with infertility and the prognosis of infertility
120. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction
121. 2+]i) transients in vascular smooth muscle cells
122. Epigenetic influences on oocyte development competence: Perifollicular vascularity and intrafollicular oxygen
123. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: Association with vascular endothelial growth factor levels and perifollicular blood flow characteristics
124. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases
125. Molecular effects of genistein on oestrogen receptor mediated pathways
126. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury
127. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition
128. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules
129. Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence
130. Thrombotic mechanisms in atherosclerosis: Potential impact of soy proteins
131. Quantification of vascular density and of lumen and vessel morphology in endometrial carcinoma. Evaluation of their relation to serum levels of tissue polypeptide-specific antigen and CA-125
132. Histochemical and ultrastructural characteristics of the endometrial connective tissue stroma from mice continuously fed diethylstilbestrol
133. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
134. Hepatic veno-occlusive disease associated with comfrey ingestion
135. The mortality experience of workers exposed to tetrachloro-dibenzo-p-dioxin in a trichlorophenol process accident
136. Markedly elevated levels of vascular endothelial growth factor in malignant ascites
137. Functional role of oestrogen metabolism in target cells. Review and perspectives